user.v1YcBgOpe0

Interested in Adding Some Web Security to Your Email Security?

Blog Post created by user.v1YcBgOpe0 Employee on Jul 27, 2018

Matthew Gardiner is a Director of Product Marketing at Mimecast, currently focused on email security, phishing, malware, and cloud security.

 

Given that you are spending some time in this Mimecast community and are reading this blog, there is an excellent chance that you are securing your email with the Mimecast family of security services. Thanks for that! Of potentially high interest to you is our upcoming entry into the web security market. 

 

I want to bring to your attention our recent public step to extend our cloud-based security service into the domain of web security. While email is generally considered to be the dominant entry point for security threats, the web certainly isn't far behind and is often a key tool for attackers. And even in email-initiated attacks, particularly when malware is involved, attackers generally pivot to using the web to execute their attacks. 

 

We think it makes a lot of sense to bring those two worlds together - email and web security - into a single service that provides an integrated, yet multi-vector defense. That is why later this year we plan to release a new cloud-based web security service - Mimecast Web Security - that provides web filtering and acceptable use controls at the DNS resolver layer of the web. A key goal of the service is to give you a security service that is easy to deploy and manage, while providing strong security bang-for-the-buck.

 

I tell you this now because we have just moved into our public phase of early-adopter testing. This is open to any existing customer of Mimecast. If you have interest in taking part in this testing period, which is estimated to remain open until September 1st, I encourage you to indicate your interest by filling out the form on this page

 

Also, we have recently pushed live a beta testing subspace here. Check it out for some more details on the service and the program.

 

If you have any questions, feel free to ask them below in the comments.

Outcomes